IBDEI1YH ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34699,1,4,0)
 ;;=4^J43.8
 ;;^UTILITY(U,$J,358.3,34699,2)
 ;;=^87569
 ;;^UTILITY(U,$J,358.3,34700,0)
 ;;=J43.1^^192^2008^28
 ;;^UTILITY(U,$J,358.3,34700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34700,1,3,0)
 ;;=3^Panlobular Emphysema
 ;;^UTILITY(U,$J,358.3,34700,1,4,0)
 ;;=4^J43.1
 ;;^UTILITY(U,$J,358.3,34700,2)
 ;;=^5008236
 ;;^UTILITY(U,$J,358.3,34701,0)
 ;;=J45.51^^192^2008^29
 ;;^UTILITY(U,$J,358.3,34701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34701,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Exacerbation
 ;;^UTILITY(U,$J,358.3,34701,1,4,0)
 ;;=4^J45.51
 ;;^UTILITY(U,$J,358.3,34701,2)
 ;;=^5008252
 ;;^UTILITY(U,$J,358.3,34702,0)
 ;;=J45.52^^192^2008^30
 ;;^UTILITY(U,$J,358.3,34702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34702,1,3,0)
 ;;=3^Severe Persistent Asthma w/ Status Asthmaticus
 ;;^UTILITY(U,$J,358.3,34702,1,4,0)
 ;;=4^J45.52
 ;;^UTILITY(U,$J,358.3,34702,2)
 ;;=^5008253
 ;;^UTILITY(U,$J,358.3,34703,0)
 ;;=J45.50^^192^2008^31
 ;;^UTILITY(U,$J,358.3,34703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34703,1,3,0)
 ;;=3^Severe Persistent Asthma,Uncomplicated
 ;;^UTILITY(U,$J,358.3,34703,1,4,0)
 ;;=4^J45.50
 ;;^UTILITY(U,$J,358.3,34703,2)
 ;;=^5008251
 ;;^UTILITY(U,$J,358.3,34704,0)
 ;;=J43.0^^192^2008^32
 ;;^UTILITY(U,$J,358.3,34704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34704,1,3,0)
 ;;=3^Unilateral Pulmonary Emphysema
 ;;^UTILITY(U,$J,358.3,34704,1,4,0)
 ;;=4^J43.0
 ;;^UTILITY(U,$J,358.3,34704,2)
 ;;=^5008235
 ;;^UTILITY(U,$J,358.3,34705,0)
 ;;=J45.901^^192^2008^3
 ;;^UTILITY(U,$J,358.3,34705,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34705,1,3,0)
 ;;=3^Asthma w/ Exacerbation,Unspec
 ;;^UTILITY(U,$J,358.3,34705,1,4,0)
 ;;=4^J45.901
 ;;^UTILITY(U,$J,358.3,34705,2)
 ;;=^5008254
 ;;^UTILITY(U,$J,358.3,34706,0)
 ;;=J45.902^^192^2008^4
 ;;^UTILITY(U,$J,358.3,34706,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34706,1,3,0)
 ;;=3^Asthma w/ Status Asthmaticus,Unspec
 ;;^UTILITY(U,$J,358.3,34706,1,4,0)
 ;;=4^J45.902
 ;;^UTILITY(U,$J,358.3,34706,2)
 ;;=^5008255
 ;;^UTILITY(U,$J,358.3,34707,0)
 ;;=J45.909^^192^2008^5
 ;;^UTILITY(U,$J,358.3,34707,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34707,1,3,0)
 ;;=3^Asthma,Uncomplicated,Unspec
 ;;^UTILITY(U,$J,358.3,34707,1,4,0)
 ;;=4^J45.909
 ;;^UTILITY(U,$J,358.3,34707,2)
 ;;=^5008256
 ;;^UTILITY(U,$J,358.3,34708,0)
 ;;=J42.^^192^2008^13
 ;;^UTILITY(U,$J,358.3,34708,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34708,1,3,0)
 ;;=3^Chr Bronchitis,Unspec
 ;;^UTILITY(U,$J,358.3,34708,1,4,0)
 ;;=4^J42.
 ;;^UTILITY(U,$J,358.3,34708,2)
 ;;=^5008234
 ;;^UTILITY(U,$J,358.3,34709,0)
 ;;=I95.1^^192^2009^1
 ;;^UTILITY(U,$J,358.3,34709,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34709,1,3,0)
 ;;=3^Orthostatic Hypotension
 ;;^UTILITY(U,$J,358.3,34709,1,4,0)
 ;;=4^I95.1
 ;;^UTILITY(U,$J,358.3,34709,2)
 ;;=^60741
 ;;^UTILITY(U,$J,358.3,34710,0)
 ;;=I73.9^^192^2009^2
 ;;^UTILITY(U,$J,358.3,34710,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34710,1,3,0)
 ;;=3^Peripheral Vascular Disease,Unspec
 ;;^UTILITY(U,$J,358.3,34710,1,4,0)
 ;;=4^I73.9
 ;;^UTILITY(U,$J,358.3,34710,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,34711,0)
 ;;=I80.13^^192^2009^3
 ;;^UTILITY(U,$J,358.3,34711,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34711,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Femoral Vein
 ;;^UTILITY(U,$J,358.3,34711,1,4,0)
 ;;=4^I80.13
 ;;^UTILITY(U,$J,358.3,34711,2)
 ;;=^5007827
 ;;^UTILITY(U,$J,358.3,34712,0)
 ;;=I80.213^^192^2009^4
 ;;^UTILITY(U,$J,358.3,34712,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34712,1,3,0)
 ;;=3^Phlebitis/Thromophlebitis Bilateral Iliac Vein
